Non-invasive risk stratification of metabolic dysfunction-associated steatotic liver disease and liver fibrosis in adults with type 1 diabetes

Non-invasive tools allow the identification of adults with T1D at increased risk for steatotic liver disease and fibrosis; however, these findings should be interpreted as risk stratification rather than definitive diagnosis.